Preliminary safety and activity evaluation of new agents for the treatment of HIV-1 infection: Recommended guidelines for trial design

Daniel Stein; Lawrence Corey; Paul Volberding; John Jermano; Dennis Dixon; Michael Feldstein; Charles Flexner; Donna Freeman; Michael Grieco; Diane Havlir; John Leedom; Ronald Mitsuyasu; Michael Para; Henry Sacks; Mindell Seidlin

doi:10.1016/0197-2456(92)90069-C

Preliminary safety and activity evaluation of new agents for the treatment of HIV-1 infection: Recommended guidelines for trial design

Daniel Stein, Lawrence Corey, Paul Volberding, John Jermano, Dennis Dixon, Michael Feldstein, Charles Flexner, Donna Freeman, Michael Grieco, Diane Havlir, John Leedom, Ronald Mitsuyasu, Michael Para, Henry Sacks, Mindell Seidlin

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	388
Number of pages	1
Journal	Controlled clinical trials
Volume	13
Issue number	5
DOIs	https://doi.org/10.1016/0197-2456(92)90069-C
State	Published - Oct 1992
Externally published	Yes

ASJC Scopus subject areas

Pharmacology

Access to Document

10.1016/0197-2456(92)90069-C

Cite this

Stein, D., Corey, L., Volberding, P., Jermano, J., Dixon, D., Feldstein, M., Flexner, C., Freeman, D., Grieco, M., Havlir, D., Leedom, J., Mitsuyasu, R., Para, M., Sacks, H., & Seidlin, M. (1992). Preliminary safety and activity evaluation of new agents for the treatment of HIV-1 infection: Recommended guidelines for trial design. Controlled clinical trials, 13(5), 388. https://doi.org/10.1016/0197-2456(92)90069-C

Stein, D, Corey, L, Volberding, P, Jermano, J, Dixon, D, Feldstein, M, Flexner, C, Freeman, D, Grieco, M, Havlir, D, Leedom, J, Mitsuyasu, R, Para, M, Sacks, H & Seidlin, M 1992, 'Preliminary safety and activity evaluation of new agents for the treatment of HIV-1 infection: Recommended guidelines for trial design', Controlled clinical trials, vol. 13, no. 5, pp. 388. https://doi.org/10.1016/0197-2456(92)90069-C

@article{cf31532c24334cc8af2ffdd5f845496c,

title = "Preliminary safety and activity evaluation of new agents for the treatment of HIV-1 infection: Recommended guidelines for trial design",

author = "Daniel Stein and Lawrence Corey and Paul Volberding and John Jermano and Dennis Dixon and Michael Feldstein and Charles Flexner and Donna Freeman and Michael Grieco and Diane Havlir and John Leedom and Ronald Mitsuyasu and Michael Para and Henry Sacks and Mindell Seidlin",

year = "1992",

month = oct,

doi = "10.1016/0197-2456(92)90069-C",

language = "English (US)",

volume = "13",

pages = "388",

journal = "Controlled clinical trials",

issn = "0197-2456",

publisher = "Elsevier BV",

number = "5",

}

TY - JOUR

T1 - Preliminary safety and activity evaluation of new agents for the treatment of HIV-1 infection

T2 - Recommended guidelines for trial design

AU - Stein, Daniel

AU - Corey, Lawrence

AU - Volberding, Paul

AU - Jermano, John

AU - Dixon, Dennis

AU - Feldstein, Michael

AU - Flexner, Charles

AU - Freeman, Donna

AU - Grieco, Michael

AU - Havlir, Diane

AU - Leedom, John

AU - Mitsuyasu, Ronald

AU - Para, Michael

AU - Sacks, Henry

AU - Seidlin, Mindell

PY - 1992/10

Y1 - 1992/10

UR - http://www.scopus.com/inward/record.url?scp=44049112472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44049112472&partnerID=8YFLogxK

U2 - 10.1016/0197-2456(92)90069-C

DO - 10.1016/0197-2456(92)90069-C

M3 - Article

AN - SCOPUS:44049112472

SN - 0197-2456

VL - 13

SP - 388

JO - Controlled clinical trials

JF - Controlled clinical trials

IS - 5

ER -

Preliminary safety and activity evaluation of new agents for the treatment of HIV-1 infection: Recommended guidelines for trial design

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this